208 related articles for article (PubMed ID: 22033491)
1. Specific deletion of TRAF3 in B lymphocytes leads to B-lymphoma development in mice.
Moore CR; Liu Y; Shao C; Covey LR; Morse HC; Xie P
Leukemia; 2012 May; 26(5):1122-7. PubMed ID: 22033491
[No Abstract] [Full Text] [Related]
2. Genetic inactivation of TRAF3 in canine and human B-cell lymphoma.
Bushell KR; Kim Y; Chan FC; Ben-Neriah S; Jenks A; Alcaide M; Fornika D; Grande BM; Arthur S; Gascoyne RD; Steidl C; Morin RD
Blood; 2015 Feb; 125(6):999-1005. PubMed ID: 25468570
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated TRAF3 and BCL2 Expression Promotes Multiple Classes of Mature Non-hodgkin B Cell Lymphoma in Mice.
Perez-Chacon G; Adrados M; Vallejo-Cremades MT; Lefebvre S; Reed JC; Zapata JM
Front Immunol; 2018; 9():3114. PubMed ID: 30687320
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs.
Xie P; Stunz LL; Larison KD; Yang B; Bishop GA
Immunity; 2007 Aug; 27(2):253-67. PubMed ID: 17723217
[TBL] [Abstract][Full Text] [Related]
5. Biallelic inactivation of TRAF3 in a subset of B-cell lymphomas with interstitial del(14)(q24.1q32.33).
Nagel I; Bug S; Tönnies H; Ammerpohl O; Richter J; Vater I; Callet-Bauchu E; Calasanz MJ; Martinez-Climent JA; Bastard C; Salido M; Schroers E; Martin-Subero JI; Gesk S; Harder L; Majid A; Dyer MJ; Siebert R
Leukemia; 2009 Nov; 23(11):2153-5. PubMed ID: 19693093
[No Abstract] [Full Text] [Related]
6. TRAF3 deficiency promotes metabolic reprogramming in B cells.
Mambetsariev N; Lin WW; Wallis AM; Stunz LL; Bishop GA
Sci Rep; 2016 Oct; 6():35349. PubMed ID: 27752131
[TBL] [Abstract][Full Text] [Related]
7. Roles of TNF receptor-associated factor 3 in signaling to B lymphocytes by carboxyl-terminal activating regions 1 and 2 of the EBV-encoded oncoprotein latent membrane protein 1.
Xie P; Bishop GA
J Immunol; 2004 Nov; 173(9):5546-55. PubMed ID: 15494504
[TBL] [Abstract][Full Text] [Related]
8. Nuclear TRAF3 is a negative regulator of CREB in B cells.
Mambetsariev N; Lin WW; Stunz LL; Hanson BM; Hildebrand JM; Bishop GA
Proc Natl Acad Sci U S A; 2016 Jan; 113(4):1032-7. PubMed ID: 26755589
[TBL] [Abstract][Full Text] [Related]
9. TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-{kappa}B activation.
He L; Grammer AC; Wu X; Lipsky PE
J Biol Chem; 2004 Dec; 279(53):55855-65. PubMed ID: 15383523
[TBL] [Abstract][Full Text] [Related]
10. TNF receptor-associated factor 3 is required for T cell-mediated immunity and TCR/CD28 signaling.
Xie P; Kraus ZJ; Stunz LL; Liu Y; Bishop GA
J Immunol; 2011 Jan; 186(1):143-55. PubMed ID: 21084666
[TBL] [Abstract][Full Text] [Related]
11. Elevated Choline Kinase α-Mediated Choline Metabolism Supports the Prolonged Survival of TRAF3-Deficient B Lymphocytes.
Gokhale S; Lu W; Zhu S; Liu Y; Hart RP; Rabinowitz JD; Xie P
J Immunol; 2020 Jan; 204(2):459-471. PubMed ID: 31826940
[TBL] [Abstract][Full Text] [Related]
12. Rescue of TRAF3-null mice by p100 NF-kappa B deficiency.
He JQ; Zarnegar B; Oganesyan G; Saha SK; Yamazaki S; Doyle SE; Dempsey PW; Cheng G
J Exp Med; 2006 Oct; 203(11):2413-8. PubMed ID: 17015635
[TBL] [Abstract][Full Text] [Related]
13. The prevalence and characterisation of TRAF3 and POT1 mutations in canine B-cell lymphoma.
Smith PAD; Waugh EM; Crichton C; Jarrett RF; Morris JS
Vet J; 2020 Dec; 266():105575. PubMed ID: 33323169
[TBL] [Abstract][Full Text] [Related]
14. Signaling mechanisms of bortezomib in TRAF3-deficient mouse B lymphoma and human multiple myeloma cells.
Edwards SK; Han Y; Liu Y; Kreider BZ; Liu Y; Grewal S; Desai A; Baron J; Moore CR; Luo C; Xie P
Leuk Res; 2016 Feb; 41():85-95. PubMed ID: 26740054
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Toll-like receptor (TLR) responses of TNFR-associated factor 3 (TRAF3)-deficient B lymphocytes.
Xie P; Poovassery J; Stunz LL; Smith SM; Schultz ML; Carlin LE; Bishop GA
J Leukoc Biol; 2011 Dec; 90(6):1149-57. PubMed ID: 21971520
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor receptor-associated factor 3 is a positive regulator of pathological cardiac hypertrophy.
Jiang X; Deng KQ; Luo Y; Jiang DS; Gao L; Zhang XF; Zhang P; Zhao GN; Zhu X; Li H
Hypertension; 2015 Aug; 66(2):356-67. PubMed ID: 26034202
[TBL] [Abstract][Full Text] [Related]
17. Exome sequencing of lymphomas from three dog breeds reveals somatic mutation patterns reflecting genetic background.
Elvers I; Turner-Maier J; Swofford R; Koltookian M; Johnson J; Stewart C; Zhang CZ; Schumacher SE; Beroukhim R; Rosenberg M; Thomas R; Mauceli E; Getz G; Palma FD; Modiano JF; Breen M; Lindblad-Toh K; Alföldi J
Genome Res; 2015 Nov; 25(11):1634-45. PubMed ID: 26377837
[TBL] [Abstract][Full Text] [Related]
18. Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.
Hildebrand JM; Yi Z; Buchta CM; Poovassery J; Stunz LL; Bishop GA
Immunol Rev; 2011 Nov; 244(1):55-74. PubMed ID: 22017431
[TBL] [Abstract][Full Text] [Related]
19. Expression and function of a novel isoform of Sox5 in malignant B cells.
Edwards SK; Desai A; Liu Y; Moore CR; Xie P
Leuk Res; 2014 Mar; 38(3):393-401. PubMed ID: 24418753
[TBL] [Abstract][Full Text] [Related]
20. Lkb1 deletion in murine B lymphocytes promotes cell death and cancer.
Souroullas GP; Fedoriw Y; Staudt LM; Sharpless NE
Exp Hematol; 2017 Jul; 51():63-70.e1. PubMed ID: 28435024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
